Search results
Chinese Drugmaker Faces Sanction in MDL After CEO Skips Deposition | New Jersey Law Journal
Law.com· 2 hours agoA pharmaceutical manufacturer based in China is facing a monetary sanction in a New Jersey court for...
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
The Independent via Yahoo News· 5 days agoAstraZeneca is withdrawing its Covid-19 vaccine worldwide, months after the pharma giant admitted...
Drugmaker Abbott India posts Q4 profit rise on higher sales
Reuters via Yahoo News· 4 days agoIndian drugmaker Abbott India reported a 24% rise in fourth-quarter profit on Thursday, as strong...
One stock is dragging down the S&P 500's earnings growth
Yahoo Finance via AOL· 8 hours agoCompanies in the S&P 500 (^GSPC) have reported what's broadly been considered a solid Q1 earnings...
What the results of Wegovy’s longest clinical trial yet show about weight loss, side effects and...
CNN via Yahoo News· 2 hours agoNew analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on...
Second Circuit dismisses suit against drugmaker that paid competitors to delay generic release
Courthouse News Service· 3 hours agoThe manufacturer of a lucrative blood pressure drug did not violate antitrust laws by paying...
Alzheimer’s vaccine licensing deal boosts AC Immune
Market Watch· 12 hours agoThe deal gives Japanese drugmaker Takeda the exclusive option to license global rights to the vaccine, known as ACI-24.060, which is designed to delay or...
Incyte, Squarespace rise; Chimera Investment, Amazon fall, Monday, 5/13/2024
U-T San Diego· 8 hours agoThe specialty drugmaker announced plans to buy back up to $2 billion of its stock. The software company Squarespace is being taken private in $6.9 billion all-cash deal with private equity firm Permira.
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 8 hours agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Heart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock Soars
Benzinga via Yahoo Finance· 6 days agoTuesday, Esperion Therapeutics (NASDAQ:ESPR) reported first-quarter revenues of $137.74 million, up...